- Home
- PRTH vs CGEM Comparison
PRTH vs CGEM Comparison
Compare PRTH & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTH
- CGEM
- Stock Information
- Founded
- PRTH 2005
- CGEM 2016
- Country
- PRTH United States
- CGEM United States
- Employees
- PRTH N/A
- CGEM N/A
- Industry
- PRTH EDP Services
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- PRTH Technology
- CGEM Health Care
- Exchange
- PRTH Nasdaq
- CGEM Nasdaq
- Market Cap
- PRTH 687.1M
- CGEM 730.2M
- IPO Year
- PRTH N/A
- CGEM 2021
- Fundamental
- Price
- PRTH $8.90
- CGEM $10.26
- Analyst Decision
- PRTH Strong Buy
- CGEM Strong Buy
- Analyst Count
- PRTH 3
- CGEM 7
- Target Price
- PRTH $13.00
- CGEM $31.67
- AVG Volume (30 Days)
- PRTH 757.2K
- CGEM 614.7K
- Earning Date
- PRTH 03-11-2025
- CGEM 03-13-2025
- Dividend Yield
- PRTH N/A
- CGEM N/A
- EPS Growth
- PRTH N/A
- CGEM N/A
- EPS
- PRTH N/A
- CGEM N/A
- Revenue
- PRTH $851,914,000.00
- CGEM N/A
- Revenue This Year
- PRTH $18.87
- CGEM N/A
- Revenue Next Year
- PRTH $10.14
- CGEM N/A
- P/E Ratio
- PRTH N/A
- CGEM N/A
- Revenue Growth
- PRTH 16.08
- CGEM N/A
- 52 Week Low
- PRTH $2.82
- CGEM $9.50
- 52 Week High
- PRTH $12.44
- CGEM $30.19
- Technical
- Relative Strength Index (RSI)
- PRTH 43.52
- CGEM 34.25
- Support Level
- PRTH $7.36
- CGEM $9.50
- Resistance Level
- PRTH $12.30
- CGEM $11.31
- Average True Range (ATR)
- PRTH 1.02
- CGEM 0.77
- MACD
- PRTH -0.40
- CGEM -0.11
- Stochastic Oscillator
- PRTH 30.34
- CGEM 21.79
About PRTH Priority Technology Holdings Inc.
Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium businesses enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments and Enterprise Payments. SMB Payments segment which generates majority revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging priority's proprietary software platform, distributed through ISO; B2B Payments segment provides AP automation solutions to corporations, software partners and industry FIs: and Enterprise Payments segment provides embedded payment and treasury solutions to enterprise customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.